Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eli Lilly offers $400M-plus deal to bag an early-stage autoimmune drug from Nektar
Eli Lilly offers $400M-plus deal to bag an early-stage autoimmune drug from Nektar
Eli Lilly offers $400M-plus deal to bag an early-stage autoimmune drug from Nektar
Submitted by
admin
on July 24, 2017 - 10:46am
Source:
Endpoints
News Tags:
Eli Lilly
autoimmune disease
NKTR-358
Nektar
Headline:
Eli Lilly offers $400M-plus deal to bag an early-stage autoimmune drug from Nektar
Do Not Allow Advertisers to Use My Personal information
